DOW vs EDIT · P/E 74, rev $42.96B vs rev $32.3M
Dow Inc (DOW) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DOW and EDIT stock pages for the full models.
Not investment advice.